Monocarboxylate transporter 1 (MCT1) inhibitor called AZD3965 killed those glycolysis-dependent tumor cells through lactate transport regulation, especially in SCLC patients with tumor expression of MCT1 and lack of MCT4 [74]. Here, SLC16A1 is linked to small cell lung carcinoma.